Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infectionsChao Zhang, Zhong Huang, Yifan Wang et al.|Nature Communications|2021Cited by 108
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infectionJinkai Zang, Zhong Huang, Yuanfei Zhu et al.|Cell Discovery|2021Cited by 70
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancementJinkai Zang, Zhong Huang, Hong Tang et al.|Cell Discovery|2020Cited by 68
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike proteinShiqi Xu, Zhong Huang, Yifan Wang et al.|Emerging Microbes & Infections|2021Cited by 31
Immunization with the receptor–binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancementJinkai Zang, Zhong Huang, Chenjian Gu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 14